Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses

Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses

Noroviruses can cause gastroenteritis and there is currently no licensed vaccine or specific treatment available. Here, the authors isolate human monoclonal antibodies and characterize one antibody (NORO-320) with broad reactivity to genogroup I and II noroviruses.

Bibliographic Details
Main Authors: Gabriela Alvarado, Wilhelm Salmen, Khalil Ettayebi, Liya Hu, Banumathi Sankaran, Mary K. Estes, B. V. Venkataram Prasad, James E. Crowe
Format: Article
Language:English
Published: Nature Publishing Group 2021-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-24649-w

Internet

https://doi.org/10.1038/s41467-021-24649-w

Similar Items